MedPath

Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials

Not Applicable
Withdrawn
Conditions
Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops
Interventions
Device: HYABAK®
Device: HYLO-COMOD®
Registration Number
NCT01546012
Lead Sponsor
Laboratoires Thea
Brief Summary

Assess the patient feeling about the handiness of two different vials used to deliver both, unpreserved hyaluronic eye drops.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Man or woman aged 18 and older
  • Patient with dry eye for at least 3 months
  • Having given his written informed consent
Exclusion Criteria
  • Intolerance to studied products
  • Patient's inability to understand the study procedures and give informed consent.
  • Patient unwilling to follow the study procedures and visits defined by the protocol.
  • Pregnant or lactating women.
  • Patient under guardian ship

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
HYABAK®HYABAK®Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)
HYLO-COMOD®:HYLO-COMOD®Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)
Primary Outcome Measures
NameTimeMethod
Overall preference of the patient6 weeks

At Visit2: Week 6 +/- 1week: End of Study Visit. "Overall preference of the patient": number of answers Hyabak, Hylo-comod.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Augenklinik

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath